KAREN CONGELIO: Open Payments
NPI 1902077696 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 64 payments from 10 companies in 2025. Trend: 2023 $669 · 2024 $1,290 · 2025 $1,180
Food & beverage: $1,108Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $334 |
| ABBVIE INC. | 20 | $282 |
| GENZYME CORPORATION | 6 | $220 |
| Novartis Pharmaceuticals Corporation | 5 | $125 |
| Lilly USA, LLC | 6 | $91 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Incyte Corporation | 1 | $26 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $9 |
| Organon LLC | 2 | $8 |
Products named: DUPIXENT, TREMFYA, RINVOQ, AXERT, EBGLYSS, SKYRIZI, COSENTYX, Zoryve.
Industry payments across PA — which companies pay providers there.
